Meeting
2021 Genitourinary Cancers Symposium
Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).
Authors
Jigi Moudgil-Joshi
The University of Edinburgh, Edinburgh, United Kingdom
Jigi Moudgil-Joshi , Mark Stares , Alex Laird , Steve Leung , Jahangeer Malik , Aravindhan Sundaramurthy , Stefan N. Symeonides
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 350)
DOI
10.1200/JCO.2021.39.6_suppl.350
Abstract #
350
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Predictive value of C reactive protein (CRP) in patients with metastatic renal cell carcinoma (mRCC) treated with pembrolizumab (pembro) and axitinib (axi).
First Author: Aitzaz Qaisar
Poster
2021 Genitourinary Cancers Symposium
Prognostic biomarkers of systemic inflammation in patients on active surveillance for metastatic renal cell carcinoma (mRCC): A biobank analysis.
First Author: Vishwani Chauhan
Poster
2021 ASCO Annual Meeting
Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
First Author: Pooja Ghatalia
Poster
2020 Genitourinary Cancers Symposium
Differences in the exposure to sunitinib in the immediate and deferred cytoreductive nephrectomy (CN) arms of the randomized controlled trial SURTIME.
First Author: Yasmin Abu-Ghanem